Literature DB >> 7495301

DNA aberrations in the epithelial cell component of adamantinoma of long bones.

H M Hazelbag1, G J Fleuren, C J Cornelisse, L J van den Broek, A H Taminiau, P C Hogendoorn.   

Abstract

Adamantinoma of long bones is a rare malignant tumor composed of cells with epithelial characteristics in various differentiation patterns surrounded by fibrous cells. Evidence as to whether this neoplasm should be designated as an epithelial bone tumor or a biphasic sarcoma with both epithelial and mesenchymal features is lacking. In this study the nature of the mesenchymal and epithelial components of adamantinoma was investigated by DNA flow cytometry, DNA image cytometry, p53 immunohistochemistry, and polymerase chain reaction-based loss of heterozygosity detection at the p53 locus. Specimens from 6 of 15 patients (40%) analyzed by flow cytometry had an aneuploid DNA index. Image cytometry analysis of Feulgen-stained paraffin sections of 6 aneuploid and 2 diploid tumors revealed that aneuploid nuclei were detected in cells with an epithelial phenotype only, whereas all fibrous cells were diploid. Immunohistochemistry for p53 on specimens from 25 patients revealed moderate or strong immunoreactivity in 12 tumors (48%) restricted to the epithelial cells. Loss of heterozygosity at the p53 locus could be confirmed in the epithelial component of an immunohistochemically p53-positive tumor. Additionally, sections of 7 lung metastases were studied histologically. Only keratin-positive epithelial cells, predominantly in the spindle cell pattern, were present in these metastases, whereas the osteofibrous tissue present in the primary tumors was not detected. These results suggest that either adamantinoma consists of a malignant epithelial part with a reactive osteofibrous stroma or that the malignant epithelial cells develop next to a proliferating benign fibrous component. Additional analysis of common genetic abnormalities in the fibrous and epithelial cells of adamantinoma is therefore indicated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495301      PMCID: PMC1869970     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

1.  Adamantinoma of long bones. A clinicopathological study of fourteen cases with vascular origin suggested.

Authors:  A G Huvos; R C Marcove
Journal:  J Bone Joint Surg Am       Date:  1975-03       Impact factor: 5.284

2.  Guidelines for implementation of clinical DNA cytometry. International Society for Analytical Cytology.

Authors:  T V Shankey; P S Rabinovitch; B Bagwell; K D Bauer; R E Duque; D W Hedley; B H Mayall; L Wheeless; C Cox
Journal:  Cytometry       Date:  1993

3.  p53 gene mutation in female genital tract carcinosarcomas (malignant mixed müllerian tumors): a clinicopathologic study of 74 cases.

Authors:  M J Costa; J Vogelsan; L J Young
Journal:  Mod Pathol       Date:  1994-08       Impact factor: 7.842

4.  Fibrous dysplasia vs adamantinoma of the tibia: differentiation based on discriminant analysis of clinical and plain film findings.

Authors:  J L Bloem; R O van der Heul; H M Schuttevaer; D Kuipers
Journal:  AJR Am J Roentgenol       Date:  1991-05       Impact factor: 3.959

5.  Morphologic diversity of long bone adamantinoma. The concept of differentiated (regressing) adamantinoma and its relationship to osteofibrous dysplasia.

Authors:  B Czerniak; R R Rojas-Corona; H D Dorfman
Journal:  Cancer       Date:  1989-12-01       Impact factor: 6.860

6.  Adamantinoma of the long bones: keratin subclass immunoreactivity pattern with reference to its histogenesis.

Authors:  H M Hazelbag; G J Fleuren; L J vd Broek; A H Taminiau; P C Hogendoorn
Journal:  Am J Surg Pathol       Date:  1993-12       Impact factor: 6.394

7.  Flow DNA analysis of primary bone tumors. Relationship between cellular DNA content and histopathologic classification.

Authors:  A Kreicbergs; C Silvferswärd; B Tribukait
Journal:  Cancer       Date:  1984-01-01       Impact factor: 6.860

8.  Adamantinoma of bone. An electron microscopic and immunohistochemical study.

Authors:  R H Knapp; M R Wick; B W Scheithauer; K K Unni
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1982

9.  A (CA)n dinucleotide repeat assay for evaluating loss of allelic heterozygosity in small and archival human brain tumor specimens.

Authors:  D N Louis; A von Deimling; B R Seizinger
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

10.  A study of the origin of 'shadow bands' seen when typing dinucleotide repeat polymorphisms by the PCR.

Authors:  X Y Hauge; M Litt
Journal:  Hum Mol Genet       Date:  1993-04       Impact factor: 6.150

View more
  5 in total

Review 1.  Adamantinoma, osteofibrous dysplasia and differentiated adamantinoma.

Authors:  Leonard B Kahn
Journal:  Skeletal Radiol       Date:  2003-03-22       Impact factor: 2.199

Review 2.  Adamantinoma: An Updated Review.

Authors:  Dimitrios N Varvarousis; Georgios P Skandalakis; Alexandra Barbouti; Georgios Papathanakos; Panagiotis Filis; Kostas Tepelenis; Aikaterini Kitsouli; Panagiotis Kanavaros; Panagiotis Kitsoulis
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

3.  Adamantinoma: a clinicopathological review and update.

Authors:  Deepali Jain; Vijay K Jain; Rakesh K Vasishta; Prabhat Ranjan; Yashwant Kumar
Journal:  Diagn Pathol       Date:  2008-02-15       Impact factor: 2.644

4.  Genetic and molecular reappraisal of spindle cell adamantinoma of bone reveals a small subset of misclassified intraosseous synovial sarcoma.

Authors:  Andrew Horvai; Nooshin K Dashti; Brian P Rubin; Scott E Kilpatrick; Erin R Rudzinski; Dolores Lopez-Terrada; Mary B Hubley; Jessica L Davis; Karen Fritchie
Journal:  Mod Pathol       Date:  2018-09-11       Impact factor: 7.842

5.  Disseminating adamantinoma of the tibia.

Authors:  A N Van Geel; H M Hazelbag; R Slingerland; M I Vermeulen
Journal:  Sarcoma       Date:  1997
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.